Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting

Authors:

Abstract
No abstract available
Funding Information
  • AstraZeneca
  • Dainippon Sumitomo Pharma
  • Japan Cardiovascular Research Foundation
  • Sanofi
  • Astellas Pharma
  • Bayer Yakuhin
  • Takeda Pharmaceutical Company
  • Japan Cardiovascular Research Foundation
  • Amgen K.K
  • Otsuka Pharmaceutical
  • Abbott Japan
  • Boehringer Ingelheim Japan
  • Bristol-Myers Squibb (20K08451)
  • Ministry of Education, Culture, Sports, Science and Technology
  • Merck Sharp and Dohme United Kingdom
  • Abbott Laboratories
  • Japan Agency for Medical Research and Development

This publication has 19 references indexed in Scilit: